TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Vicore Pharma AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
523
|
2,841
|
2,936 |
| Financial expenses |
2
|
5
|
433 |
| Earnings before taxes |
-281,842
|
-276,145
|
-291,864 |
| EBITDA |
-269,735
|
-276,303
|
-289,873 |
| Total assets |
114,353
|
122,401
|
186,987 |
| Current assets |
113,309
|
107,799
|
176,826 |
| Current liabilities |
69,791
|
49,157
|
91,380 |
| Equity capital |
43,752
|
72,261
|
95,362 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
19
|
16
|
12 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
38.3%
|
59.0%
|
51.0% |
| Turnover per employee |
28
|
178
|
245 |
| Profit as a percentage of turnover |
-53889.5%
|
-9720.0%
|
-9940.9% |
| Return on assets (ROA) |
-246.5%
|
-225.6%
|
-155.9% |
| Current ratio |
162.4%
|
219.3%
|
193.5% |
| Return on equity (ROE) |
-644.2%
|
-382.1%
|
-306.1% |
| Change turnover |
-2,318
|
-95
|
-37 |
| Change turnover % |
-82%
|
-3%
|
-1% |
| Chg. No. of employees |
3
|
4
|
3 |
| Chg. No. of employees % |
19%
|
33%
|
33% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.